Sun Pharma asks shareholders to reclassify a 1.80% promoter-group holding as public

Exchange no-objection letters are in place; shareholder approval would reduce promoter-group ownership to 52.68% without changing control or paid-up capital.

INDIAN MARKET GRID EDITORIAL DESK4 MIN READPUBLIC PREVIEW

MEMBER PREVIEW

Exchange no-objection letters are in place; shareholder approval would reduce promoter-group ownership to 52.68% without changing control or paid-up capital.

FREE MEMBER LOGIN

LOGIN TO CONTINUE READING.

Create or use your free IMG login to read standard articles. Important and Premium analysis also requires an active ₹99 or ₹199 plan.

The public preview and the member article share the same canonical page. No personalised investment recommendation is provided.